GENITOURINARY CANCERS

Latest News

TP53, RB1, PTEN Mutations Linked to Worse Survival in Prostate Cancer
TP53, RB1, PTEN Mutations Linked to Worse Survival in Prostate Cancer

March 8th 2024

In an interview with Targeted Oncology, Rohan Garje, MD, discussed how mutations such as TP53, RB1, and PTEN impact overall survival in patients with metastatic prostate cancer.

NCCN Recommends First AI Prognostic Tool in Prostate Cancer
NCCN Recommends First AI Prognostic Tool in Prostate Cancer

March 5th 2024

ECOG Score Predicts Survival Across Metastatic Prostate Cancer Settings
ECOG Score Predicts Survival Across Metastatic Prostate Cancer Settings

February 3rd 2024

Subcutaneous Nivolumab Delivers Clinical Equipoise to Standard IV Dosing in ccRCC
Subcutaneous Nivolumab Delivers Clinical Equipoise to Standard IV Dosing in ccRCC

January 27th 2024

Adjuvant Pembrolizumab Notably Improves OS vs Placebo in ccRCC
Adjuvant Pembrolizumab Notably Improves OS vs Placebo in ccRCC

January 27th 2024

Video Series
Video Interviews
Podcasts

More News